8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Patterns in how people eat and what happens to them. Shows an association, not proof.
2014 / Cross-sectional study
Researchers examined whether adherence to 'Blood-Type' diets was associated with cardiometabolic biomarkers and if ABO genotype modified these associations in 1,455 participants. Adherence to the Type-A diet was associated with lower BMI, waist circumference, blood pressure, serum cholesterol, triglycerides, insulin, HOMA-IR, and HOMA-Beta (P<0.05). The Type-AB diet was linked to lower levels of these biomarkers (P<0.05) except BMI and waist circumference, while the Type-O diet was associated with lower triglycerides (P<0.0001); no significant associations were found for the Type-B diet. Matching the diets to an individual's corresponding blood group did not change effect sizes, failing to support the 'Blood-Type' diet hypothesis.
Shows an association, not proof of cause and effect.
Wang J, García-Bailo B, Nielsen DE, et al. PLoS One, 2014. PMID 24454746
2014 / Prospective cohort study
The Cohort of Swedish Men followed 36,882 men aged 45-79 years for 11.7 years to evaluate associations between iron intake and acute myocardial infarction (AMI). During follow-up, 678 fatal and 2,593 nonfatal AMI events occurred. Men in the highest versus lowest quintile of heme iron intake had an increased risk of fatal AMI (HR 1.51, 95% CI: 1.07-2.13, P-trend=0.02), which was stronger among men with combined intakes of calcium, magnesium, and zinc below the medians (HR 2.89, 95% CI: 1.43-5.82). Heme iron intake was not associated with nonfatal AMI, and non-heme iron intake was not associated with fatal or nonfatal AMI.
Shows an association, not proof of cause and effect.
Kaluza J, Larsson SC, Håkansson N, et al. Int J Cardiol, 2014. PMID 24456871
2014 / Prospective cohort and repeated cross-sectional study
Researchers examined trends in added sugar intake among 31,147 US adults and analyzed prospective cardiovascular disease (CVD) mortality among 11,733 adults followed for a median of 14.6 years (831 CVD deaths). Mean calories from added sugar rose to 16.8% in 1999-2004 before declining to 14.9% in 2005-2010, when 71.4% consumed >=10% of calories from added sugar. In fully adjusted models, CVD mortality hazard ratios across quintiles of added sugar were 1.00 (reference), 1.07, 1.18, 1.38, and 2.03 (95% CI, 1.26-3.27; P = .004). Compared with consuming <10% of calories from added sugar, adjusted HRs were 1.30 (95% CI, 1.09-1.55) for 10.0%-24.9% and 2.75 (95% CI, 1.40-5.42; P = .004) for >=25.0%.
Shows an association, not proof of cause and effect.
Yang Q, Zhang Z, Gregg EW, et al. JAMA Intern Med, 2014. PMID 24493081
2014 / Prospective cohort study
Researchers examined fasting plasma choline and betaine levels in relation to TMAO and 3-year risk of major adverse cardiac events (MACE) in 3,903 stable cardiac patients. Higher plasma choline and betaine levels were associated with a 1.9-fold and 1.4-fold increased risk of MACE, respectively (Quartile 4 vs. 1; P < 0.01 each). After adjustment for traditional cardiovascular risk factors and hs-CRP, elevated choline (HR 1.34, 95% CI 1.03-1.74) and betaine (HR 1.33, 95% CI 1.03-1.73) remained predictive of MACE. However, neither predicted MACE risk when TMAO was added to the adjustment model, predicting future risk only when TMAO was elevated.
Shows an association, not proof of cause and effect.
Wang Z, Tang WH, Buffa JA, et al. Eur Heart J, 2014. PMID 24497336
2014 / Pilot cohort study
This pilot cohort study examined the Complete Health Improvement Program (CHIP), a community-based, comprehensive lifestyle modification approach, in an underserved, rural, and vulnerable Appalachian population. Two hundred fourteen participants in CHIP collectively demonstrated significant reductions in body mass index, systolic and diastolic blood pressure, and fasting blood levels of total cholesterol, low-density lipoprotein, and glucose.
Shows an association, not proof of cause and effect.
Drozek D, Diehl H, Nakazawa M, et al. Adv Prev Med, 2014. PMID 24527219
2014 / Prospective cohort study
In the NIH-AARP Diet and Health Study (n = 492,823), researchers evaluated adherence to four dietary indices (HEI-2010, AHEI-2010, aMED, and DASH) using a 124-item food-frequency questionnaire. Over 15 years of follow-up, 86,419 deaths occurred, including 23,502 from CVD and 29,415 from cancer. Higher scores on all indices were associated with a 12-28% decreased risk of all-cause, CVD, and cancer mortality. Comparing the highest with the lowest quintiles, adjusted HRs for all-cause mortality ranged from 0.76 to 0.83 in men and from 0.76 to 0.78 in women, with high adherence to each index also showing protective associations for CVD and cancer mortality separately.
Shows an association, not proof of cause and effect.
Reedy J, Krebs-Smith SM, Miller PE, et al. J Nutr, 2014. PMID 24572039
2014 / Pooled analysis of 11 prospective cohort studies
Data from 11 prospective cohort studies including 650,386 white adults were pooled to assess the association of waist circumference with mortality across BMI ranges. During a median follow-up of 9 years, 78,268 participants died. After adjusting for age, study, BMI, smoking, alcohol, and physical activity, waist circumference showed a positive linear association with all-cause mortality in men (HR 1.52 for ≥110 vs <90 cm; HR 1.07 per 5-cm increment) and women (HR 1.80 for ≥95 vs <70 cm; HR 1.09 per 5-cm increment). Estimated decreases in life expectancy for highest versus lowest waist circumference were approximately 3 years for men and 5 years for women.
Shows an association, not proof of cause and effect.
Cerhan JR, Moore SC, Jacobs EJ, et al. Mayo Clin Proc, 2014. PMID 24582192
2014 / Repeated cross-sectional survey analysis
Using Health Survey for England data from 2003 to 2011, researchers evaluated population-level changes in salt intake, blood pressure, and cardiovascular mortality. During this period, stroke mortality decreased by 42% (p<0.001) and IHD mortality by 40% (p<0.001), alongside a blood pressure drop of 3.0±0.33/1.4±0.20 mm Hg (p<0.001) and a 1.4 g/day decrease in salt intake (p<0.01). In participants not on antihypertensive medication, blood pressure fell by 2.7±0.34/1.1±0.23 mm Hg after multivariable adjustment. Parallel improvements occurred in cholesterol, smoking rates, and fruit/vegetable intake, whereas BMI increased; salt intake was not measured directly in all participants.
Shows an association, not proof of cause and effect.
He FJ, Pombo-Rodrigues S, Macgregor GA BMJ Open, 2014. PMID 24732242
2014 / Prospective cohort study
A prospective study tracked 91,223 Japanese men and women aged 40-69 years over 15-18 years of follow-up, updating rice consumption across 3 food-frequency questionnaires. Researchers ascertained 4,395 incident stroke cases, 1,088 incident ischemic heart disease (IHD) cases, and 2,705 CVD deaths. Comparing the highest to the lowest quintiles of cumulative average rice intake, multivariable hazard ratios were 1.01 (95% CI: 0.90, 1.14) for total stroke, 1.08 (95% CI: 0.84, 1.38) for IHD, and 0.97 (95% CI: 0.84, 1.13) for total CVD mortality. No interactions with sex or effect modifications by body mass index were observed for any endpoint.
Shows an association, not proof of cause and effect.
Eshak ES, Iso H, Yamagishi K, et al. Am J Clin Nutr, 2014. PMID 24740204
2014 / Prospective cohort study
In the InCHIANTI prospective cohort study of 783 community-dwelling adults aged 65 or older followed for 9 years, 268 participants (34.3%) died. Across quartiles of baseline 24-hour urinary resveratrol metabolites, all-cause mortality rates were 34.4%, 31.6%, 33.5%, and 37.4% (P = .67), with an adjusted hazard ratio of 0.80 (95% CI, 0.54-1.17) comparing the lowest to the highest quartile. Resveratrol levels were not significantly associated with inflammatory markers (CRP, IL-6, IL-1β, TNF), cardiovascular disease, or cancer.
Shows an association, not proof of cause and effect.
Semba RD, Ferrucci L, Bartali B, et al. JAMA Intern Med, 2014. PMID 24819981
2014 / Prospective cohort study within a trial cohort
Investigators followed 7,216 participants at high cardiovascular risk for a median of 4.8 years to evaluate the association between an a priori provegetarian food pattern score and all-cause mortality. Over follow-up, 323 deaths occurred (76 cardiovascular, 130 cancer, 117 noncancer/noncardiovascular). Higher baseline conformity with the provegetarian food pattern was associated with lower mortality (multivariable-adjusted HR for ≥40 vs. <30 points: 0.59; 95% CI: 0.40, 0.88), with similar results when using updated dietary information (RR: 0.59; 95% CI: 0.39, 0.89).
Shows an association, not proof of cause and effect.
Martínez-González MA, Sánchez-Tainta A, Corella D, et al. Am J Clin Nutr, 2014. PMID 24871477
2014 / Observational prospective cohort study
In an observational prospective cohort analysis of 7,216 participants followed for a median of 4.8 years, 277 cardiovascular events and 323 deaths occurred. Compared with the reference, the highest tertile of baseline total olive oil and extra-virgin olive oil consumption was associated with reduced cardiovascular disease risk (HR: 0.65; 95% CI: 0.47 to 0.89 and HR: 0.61; 95% CI: 0.44 to 0.85, respectively). Higher baseline total olive oil was associated with a 48% lower risk of cardiovascular mortality (HR: 0.52; 95% CI: 0.29 to 0.93). Each 10 g/d increase in extra-virgin olive oil was associated with 10% lower cardiovascular disease and 7% lower mortality risk, with no significant associations for cancer or all-cause mortality.
Shows an association, not proof of cause and effect.
NANO counterpoint →
Guasch-Ferré M, Hu FB, Martínez-González MA, et al. BMC Med, 2014. PMID 24886626
2014 / Pooled analysis of 20 prospective studies
A pooled analysis of 20 prospective cohort studies from the US, Sweden, and Australia evaluated mortality risks and years of life lost in class III obesity (BMI 40.0-59.9 kg/m2) versus normal weight (BMI 18.5-24.9 kg/m2). Mortality rates per 100,000 person-years were 856.0 in men and 663.0 in women with class III obesity, compared to 346.7 and 280.5 in normal-weight men and women. Heart disease contributed most to excess rates (rate differences: 238.9 in men, 132.8 in women), followed by cancer and diabetes. Compared with normal weight, BMIs of 40-44.9, 45-49.9, 50-54.9, and 55-59.9 kg/m2 were associated with an estimated 6.5, 8.9, 9.8, and 13.7 years of life lost, respectively. A key limitation was that BMI was mainly ascertained by self-report.
Shows an association, not proof of cause and effect.
Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. PLoS Med, 2014. PMID 25003901
2014 / Prospective cohort study
Researchers evaluated how four diet quality indices (HEI-2010, AHEI-2010, aMED, and DASH) relate to mortality risks among 63,805 postmenopausal women followed for 12.9 years, during which 5,692 deaths occurred (1,483 from CVD and 2,384 from cancer). After adjustment for multiple covariates, better diet quality across all four indices was linked to an 18%-26% lower all-cause and CVD mortality risk. Higher HEI, aMED, and DASH scores—though not AHEI scores—were also associated with a 20%-23% lower risk of cancer death.
Shows an association, not proof of cause and effect.
George SM, Ballard-Barbash R, Manson JE, et al. Am J Epidemiol, 2014. PMID 25035143
2014 / Prospective cohort study
Researchers examined associations of running with all-cause and cardiovascular mortality in 55,137 adults followed for a mean of 15 years, during which 3,413 all-cause and 1,217 cardiovascular deaths occurred. Compared with nonrunners, runners had 30% and 45% lower adjusted risks of all-cause and cardiovascular mortality, respectively, alongside a 3-year life expectancy benefit. Mortality benefits were similar across quintiles of running characteristics, with weekly running even <51 min, <6 miles, 1 to 2 times, or <6 miles/h linked to reduced risk. Persistent runners had 29% and 50% lower risks of all-cause and cardiovascular mortality, respectively, compared with never-runners.
Shows an association, not proof of cause and effect.
Lee DC, Pate RR, Lavie CJ, et al. J Am Coll Cardiol, 2014. PMID 25082581
2014 / Prospective cohort study
Researchers evaluated the association between home incense burning and cardiovascular mortality among 63,257 Singapore Chinese participants followed from 1993-1998 through 2011. Overall, 76.9% were current incense users, with 89.9% of them having burned incense daily for at least 20 years. Current users had a 12% higher risk of cardiovascular mortality compared to noncurrent users (multivariable adjusted HR = 1.12; 95% CI: 1.04, 1.20), including higher risks for stroke mortality (HR = 1.19; 95% CI: 1.03, 1.37) and coronary heart disease mortality (HR = 1.10; 95% CI: 1.00, 1.21). The association was restricted to participants without a baseline history of cardiovascular disease (HR = 1.16; 95% CI: 1.07, 1.26) and was stronger in never-smokers (HR = 1.12) and former smokers (HR = 1.19) than in current smokers.
Shows an association, not proof of cause and effect.
Pan A, Clark ML, Ang LW, et al. Environ Health Perspect, 2014. PMID 25127437
2014 / Prospective cohort study
Researchers followed 198 consecutive patients with established cardiovascular disease who received counseling to transition to plant-based nutrition, defined as eliminating dairy, fish, meat, and added oil. Of the 198 patients, 177 (89%) were adherent. Over a mean follow-up of 3.7 years, major cardiac events judged to be recurrent disease totaled one stroke in adherent participants (a 0.6% recurrent event rate), while 13 of 21 (62%) nonadherent participants experienced adverse events.
Shows an association, not proof of cause and effect.
Esselstyn CB, Gendy G, Doyle J, et al. J Fam Pract, 2014. PMID 25198208
2014 / Prospective cohort study
Researchers evaluated 2,258 women and 1,840 men who survived a first myocardial infarction (MI) to examine associations between low-carbohydrate diets (LCD) and mortality. Adherence to an LCD high in animal protein and fat was associated with higher all-cause mortality (HR 1.33; 95% CI: 1.06 to 1.65) and cardiovascular mortality (HR 1.51; 95% CI: 1.09 to 2.07) comparing extreme quintiles. An increase in adherence to an animal-based LCD from pre- to post-MI was also linked to higher all-cause (HR 1.30; 95% CI: 1.03 to 1.65) and cardiovascular mortality (HR 1.53; 95% CI: 1.10 to 2.13). An increase in adherence to a plant-based LCD was not associated with lower all-cause or cardiovascular mortality.
Shows an association, not proof of cause and effect.
Li S, Flint A, Pai JK, et al. J Am Heart Assoc, 2014. PMID 25246449
2014 / Retrospective pre-post cohort study
A retrospective analysis evaluated 1,615 participants in a 10-day residential program consuming an ad libitum low-fat (≤10% of calories), high-carbohydrate (~80% of calories), purely plant-based diet for 7 days. Median weight decreased by 1.4 kg (IQR 1.8) and total cholesterol decreased by 22 mg/dL (IQR 29) (both p < .001). Despite reduction or discontinuation of most antihypertensive and antihyperglycemic medications at baseline, systolic blood pressure decreased by a median of 8 mm Hg (IQR 18), diastolic blood pressure by 4 mm Hg (IQR 10), and blood glucose by 3 mg/dL (IQR 11) (all p < .001). Among participants with a baseline 10-year cardiovascular risk >7.5%, risk dropped to 5.5% at day 7 (p < .001).
Shows an association, not proof of cause and effect.
McDougall J, Thomas LE, McDougall C, et al. Nutr J, 2014. PMID 25311617
2014 / Observational case-control study
Researchers compared coronary artery plaque using high-resolution coronary computed tomographic angiography (CCTA) between veteran male marathon runners and sedentary controls. Male marathon runners (n = 50) had significantly higher total plaque volume (200 vs. 126 mm3, p < 0.01), calcified plaque volume (84 vs. 44 mm3, p < 0.0001), and non-calcified plaque volume (116 vs. 82 mm3, p = 0.04) compared to controls (n = 23). Differences in lesion area and length, number of lesions per subject, and diameter stenosis did not reach statistical significance.
Shows an association, not proof of cause and effect.
Schwartz RS, Kraus SM, Schwartz JG, et al. Mo Med, 2014. PMID 30323509
2013 / Economic and epidemiological modeling / observational analysis
This study evaluated whether changes in food prices relate to cholesterol levels and if taxes or subsidies could effectively lower cholesterol and cardiovascular disease costs. The authors found that prices of vegetables, processed foods, whole milk, and whole grains are significantly associated with blood cholesterol levels. Based on a cost-benefit analysis of government interventions, the study suggests that subsidizing vegetables and whole grains would efficiently reduce CVD expenditures.
Shows an association, not proof of cause and effect.
Rahkovsky I, Gregory CA Econ Hum Biol, 2013. PMID 22365570
2013 / Cross-sectional study
In a cross-sectional study of 247 patients at increased cardiovascular risk, dietary intake was assessed via a 3-day food-intake register and scored with a low-carbohydrate diet score (LCDS). Patients in the lowest LCDS quartile had significantly higher saRHI values than those in the highest quartile (1.66 vs 1.52, P=0.037), with particularly strong differences in those with metabolic syndrome (1.82 vs 1.61, P=0.021) and type 2 diabetes (1.78 vs 1.62, P=0.011). In multivariate analysis, being in the highest LCDS quartile was independently associated with a negative coefficient of saRHI (OR -0.85; 95% CI 0.19, 0.92; P=0.031).
Shows an association, not proof of cause and effect.
Merino J, Kones R, Ferré R, et al. Br J Nutr, 2013. PMID 22850317
2013 / Cross-sectional analysis of two cohorts
Researchers analyzed the associations of fish consumption, serum omega-3 PUFAs, and environmental contaminants (PCDD/F+PCBs and MeHg) with CVD risk factors in two Finnish cohorts (n=1,173 and n=255). Serum triglycerides decreased across omega-3 PUFA tertiles in both sexes and studies, while insulin resistance, C-reactive protein, TNF-α, and IL-6 decreased across omega-3 tertiles in the Health 2000 cohort. Among Fishermen study men, insulin resistance and arterial stiffness tended to increase across tertiles of PCDD/F+PCB and MeHg, whereas the relative risk estimate for carotid artery plaque tended to decrease.
Shows an association, not proof of cause and effect.
Turunen AW, Jula A, Suominen AL, et al. Environ Res, 2013. PMID 23089109
2013 / Prospective cohort study within a randomized trial
Researchers analyzed 2213 participants at high risk for CVD from the PREDIMED trial to examine associations between changes in bread consumption and 4-year changes in weight and waist circumference. Over 4 years, participants in the highest quartile of change in white bread intake gained 0.76 kg more weight (P for trend = 0.003) and 1.28 cm more waist circumference (P for trend < 0.001) than those in the lowest quartile. Participants in the highest quartile of white bread intake changes had a 33% reduction in the odds of losing >2 kg and a 36% reduction in the odds of losing >2 cm waist circumference. No significant dose-response relationships were observed for changes in whole-grain bread consumption and anthropometric measures.
Shows an association, not proof of cause and effect.
Bautista-Castaño I, Sánchez-Villegas A, Estruch R, et al. Br J Nutr, 2013. PMID 23199451